Fine Mapping of the NRG1 Hirschsprung's Disease Locus

The primary pathology of Hirschsprung's disease (HSCR, colon aganglionosis) is the absence of ganglia in variable lengths of the hindgut, resulting in functional obstruction. HSCR is attributed to a failure of migration of the enteric ganglion precursors along the developing gut. RET is a key regulator of the development of the enteric nervous system (ENS) and the major HSCR-causing gene. Yet the reduced penetrance of RET DNA HSCR-associated variants together with the phenotypic variability suggest the involvement of additional genes in the disease. Through a genome-wide association study, we uncovered a ∼350 kb HSCR-associated region encompassing part of the neuregulin-1 gene (NRG1). To identify the causal NRG1 variants contributing to HSCR, we genotyped 243 SNPs variants on 343 ethnic Chinese HSCR patients and 359 controls. Genotype analysis coupled with imputation narrowed down the HSCR-associated region to 21 kb, with four of the most associated SNPs (rs10088313, rs10094655, rs4624987, and rs3884552) mapping to the NRG1 promoter. We investigated whether there was correlation between the genotype at the rs10088313 locus and the amount of NRG1 expressed in human gut tissues (40 patients and 21 controls) and found differences in expression as a function of genotype. We also found significant differences in NRG1 expression levels between diseased and control individuals bearing the same rs10088313 risk genotype. This indicates that the effects of NRG1 common variants are likely to depend on other alleles or epigenetic factors present in the patients and would account for the variability in the genetic predisposition to HSCR.

[1]  S. Borrego,et al.  Ancestral RET haplotype associated with Hirschsprung’s disease shows linkage disequilibrium breakpoint at −1249 , 2005, Journal of Medical Genetics.

[2]  You-Qiang Song,et al.  Chinese patients with sporadic Hirschsprung’s disease are predominantly represented by a single RET haplotype , 2003, Journal of medical genetics.

[3]  F. Couch,et al.  Common breast cancer predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers , 2008 .

[4]  Masashi Yanagisawa,et al.  A missense mutation of the endothelin-B receptor gene in multigenic hirschsprung's disease , 1994, Cell.

[5]  J. Gusella,et al.  Familial dysautonomia. , 2002, Current opinion in genetics & development.

[6]  A. Chakravarti,et al.  Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient , 1996, Nature Genetics.

[7]  Y. Ishigaki,et al.  Ventromedial hypothalamic lesions change the expression of neuron-related genes and immune-related genes in rat liver , 2009, Neuroscience Letters.

[8]  R. Ravazzolo,et al.  Single nucleotide polymorphic alleles in the 5′ region of the RET proto-oncogene define a risk haplotype in Hirschsprung’s disease , 2003, Journal of medical genetics.

[9]  J. Epstein,et al.  Pax3 is required for enteric ganglia formation and functions with Sox10 to modulate expression of c-ret. , 2000, The Journal of clinical investigation.

[10]  J. Testa,et al.  Association of Lbc Rho guanine nucleotide exchange factor with alpha-catenin-related protein, alpha-catulin/CTNNAL1, supports serum response factor activation. , 2002, The Journal of biological chemistry.

[11]  A. Munnich,et al.  Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome , 2003, Nature Genetics.

[12]  B. Rubin,et al.  Familial dysautonomia is caused by mutations of the IKAP gene. , 2001, American journal of human genetics.

[13]  I. Vinograd,et al.  Congenital megacolon associated with familial dysautonomia , 1984, European Journal of Pediatrics.

[14]  M. Ruíz-Ferrer,et al.  A Novel Point Variant in NTRK3, R645C, Suggests a Role of this Gene in the Pathogenesis of Hirschsprung Disease , 2009, Annals of human genetics.

[15]  S. Gabriel,et al.  Whole-genome association study of bipolar disorder , 2008, Molecular Psychiatry.

[16]  A. Nissan,et al.  Decreased density of ganglia and neurons in the myenteric plexus of familial dysautonomia patients , 2004, Journal of the Neurological Sciences.

[17]  V. Pachnis,et al.  Expression profiling the developing mammalian enteric nervous system identifies marker and candidate Hirschsprung disease genes. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Dietmar Roesner,et al.  Functional haplotypes of the RET proto-oncogene promoter are associated with Hirschsprung disease (HSCR). , 2003, Human molecular genetics.

[19]  B. Pasini,et al.  Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease , 1994, Nature.

[20]  P. Heutink,et al.  A novel susceptibility locus for Hirschsprung’s disease maps to 4q31.3–q32.3 , 2005, Journal of Medical Genetics.

[21]  Carel Meijers,et al.  A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome) , 1996, Nature Genetics.

[22]  J. Epstein,et al.  Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer. , 2003, Human molecular genetics.

[23]  J. Osinga,et al.  Localizing a putative mutation as the major contributor to the development of sporadic Hirschsprung disease to the RET genomic sequence between the promoter region and exon 2 , 2004, European Journal of Human Genetics.

[24]  Aravinda Chakravarti,et al.  Phenotype variation in two-locus mouse models of Hirschsprung disease: Tissue-specific interaction between Ret and Ednrb , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[26]  Carel Meijers,et al.  Homozygous nonsense mutations in KIAA1279 are associated with malformations of the central and enteric nervous systems. , 2005, American journal of human genetics.

[27]  P. Sham,et al.  Genome-wide association study identifies NRG1 as a susceptibility locus for Hirschsprung's disease , 2009, Proceedings of the National Academy of Sciences.

[28]  J. Osinga,et al.  RET and GDNF gene scanning in Hirschsprung patients using two dual denaturing gel systems , 2000, Human mutation.

[29]  C Maayan,et al.  Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. , 2001, American journal of human genetics.

[30]  A. Chakravarti,et al.  A genetic study of Hirschsprung disease. , 1990, American journal of human genetics.

[31]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[32]  Warren C. Lathe,et al.  Prediction of deleterious human alleles. , 2001, Human molecular genetics.

[33]  J. Osinga,et al.  A loss-of-function mutation in the endothelin-converting enzyme 1 (ECE-1) associated with Hirschsprung disease, cardiac defects, and autonomic dysfunction. , 1999, American journal of human genetics.

[34]  Dietmar Roesner,et al.  Association between c135G/A genotype and RET proto-oncogene germline mutations and phenotype of Hirschsprung's disease , 2002, The Lancet.

[35]  M. Brownstein,et al.  Of splice and men: what does the distribution of IKAP mRNA in the rat tell us about the pathogenesis of familial dysautonomia? , 2003, Brain Research.

[36]  H. Schackert,et al.  Within-gene interaction between c.135 G/A genotypes and RET proto-oncogene germline mutations in HSCR families. , 2003, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie.

[37]  Kevin M. Bradley,et al.  Interactions between Sox10 and EdnrB modulate penetrance and severity of aganglionosis in the Sox10Dom mouse model of Hirschsprung disease. , 2004, Human molecular genetics.

[38]  A. Chakravarti,et al.  A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[39]  A Chakravarti,et al.  Hirschsprung disease, associated syndromes and genetics: a review , 2001, Journal of Medical Genetics.

[40]  J. Osinga,et al.  Identifying candidate Hirschsprung disease-associated RET variants. , 2005, American journal of human genetics.

[41]  P. Sham,et al.  TTF-1 and RET promoter SNPs: regulation of RET transcription in Hirschsprung's disease. , 2005, Human molecular genetics.

[42]  B. Ponder,et al.  Mutations of the RET proto-oncogene in Hirschsprung's disease , 1994, Nature.

[43]  Giovanni Romeo,et al.  SOX10 mutations in patients with Waardenburg-Hirschsprung disease , 1998, Nature Genetics.

[44]  Misha Angrist,et al.  Segregation at three loci explains familial and population risk in Hirschsprung disease , 2002, Nature Genetics.

[45]  N. Nomura,et al.  Mutations in SIP1, encoding Smad interacting protein-1, cause a form of Hirschsprung disease , 2001, Nature Genetics.

[46]  Minerva M. Carrasquillo,et al.  Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease , 2002, Nature Genetics.